Davis v. Honeywell International Inc. , 199 Cal. Rptr. 3d 583 ( 2016 )


Menu:
  • Filed 3/3/16
    CERTIFIED FOR PUBLICATION
    IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA
    SECOND APPELLATE DISTRICT
    DIVISION FOUR
    NICKOLE DAVIS, as Personal                   B256793
    Representative, etc.,
    (Los Angeles County
    Plaintiff and Respondent,             Super. Ct. No. JCCP4674/BC469472)
    v.
    HONEYWELL INTERNATIONAL
    INC.,
    Defendant and Appellant.
    APPEAL from a judgment of the Superior Court for Los Angeles County,
    Victor E. Chavez, Judge. Affirmed.
    Perkins Coie, Brien F. McMahon, Aaron R. Goldstein; Horvitz & Levy, Lisa
    Perrochet and Robert H. Wright for Defendant and Appellant.
    Karst & Von Oiste and George H. Kim for Plaintiff and Respondent.
    In Rutherford v. Owens-Illinois, Inc. (1997) 
    16 Cal. 4th 953
    (Rutherford), the
    California Supreme Court addressed the burden on a plaintiff in an asbestos-related
    cancer case to prove that the defendant’s product was a legal cause of the
    plaintiff’s (or the plaintiff’s decedent’s) injuries. The Supreme Court held that
    such a plaintiff “may prove causation . . . by demonstrating that the plaintiff’s
    exposure to defendant’s asbestos-containing product in reasonable medical
    probability was a substantial factor in contributing to the aggregate dose of
    asbestos the plaintiff or decedent inhaled or ingested, and hence to the risk of
    developing asbestos-related cancer.” (Id. at pp. 976-977, fn. omitted.) To meet
    this burden, many plaintiffs in asbestos cases (including the plaintiff in Rutherford)
    present testimony from medical experts who espouse the theory that exposure to
    even low doses of asbestos contributes to the development of mesothelioma, an
    asbestos-related cancer. (See 
    id. at p.
    984 [plaintiff’s expert opined “that each
    exposure, even a relatively small one, contributed to the occupational ‘dose’ and
    hence to the risk of cancer,” and therefore the plaintiff’s exposure to defendant’s
    product, even if very small, was a substantial factor in contributing to the risk of
    developing cancer].)
    In the case before us, plaintiff Nickole Davis1 presented such expert
    testimony at trial in support of her claim that her father’s exposure to asbestos in
    Bendix brake linings that he used when performing brake jobs in the 1960s and
    1970s was a substantial factor in contributing to his risk of developing
    mesothelioma. In this appeal from the judgment entered on a jury verdict in
    1
    Nickole Davis appears in this action in her capacity of personal representative of
    her deceased father, Sam Davis. To avoid confusion, we will refer to Nickole Davis as
    “plaintiff” and to Sam Davis as “Davis.”
    2
    plaintiff’s favor, defendant Honeywell International Inc. (Honeywell)2 contends
    that this opinion testimony – which commonly is referred to as the “every
    exposure,” “any exposure,” or “any fiber” theory – should have been excluded
    under Sargon Enterprises, Inc. v. University of Southern California (2012) 
    55 Cal. 4th 747
    (Sargon), because it is speculative and devoid of evidentiary and
    logical support.
    Having reviewed much of the commentary and scientific literature cited in
    support of and against the “every exposure” theory, we conclude the theory is the
    subject of legitimate scientific debate. Because in ruling on the admissibility of
    expert testimony the trial court “does not resolve scientific controversies” 
    (Sargon, supra
    , 55 Cal.4th at p. 772), it is for the jury to resolve the conflict between the
    every exposure theory and any competing expert opinions. 
    (Rutherford, supra
    , 16
    Cal.4th at p. 984 [noting conflicting expert opinions were presented to jury, and
    jury rejected defense expert’s testimony that “a very light or brief exposure could
    be considered ‘insignificant or at least nearly so’” in assessing whether the
    exposure was a substantial factor in contributing to plaintiff’s risk of developing
    cancer].) Therefore, we hold the trial court did not abuse its discretion by allowing
    plaintiff’s medical expert to testify.
    The other issue presented in this appeal is whether the trial court erred in
    refusing to give Honeywell’s proposed supplemental jury instruction based upon
    language in Rutherford regarding factors that may be relevant in determining
    whether a plaintiff’s exposure to a particular asbestos-containing product should be
    deemed a substantial factor in causing the cancer at issue. We conclude the issue
    of causation was adequately covered by the jury instructions given, and therefore
    2
    Honeywell concedes it is responsible for injuries caused by brake products
    manufactured by The Bendix Company.
    3
    hold the trial court did not err by refusing to give Honeywell’s proposed
    instruction.
    BACKGROUND
    Plaintiff’s father, Sam Davis, was born in 1943, in Mobile, Alabama. As a
    child, he travelled around the country with his family picking crops. In the early
    1960s, when he was around 20 years old, he moved to Downey, California, where
    he lived until the late 1970s. In 1963 or 1964, Davis began doing automotive work
    (primarily brake jobs) and home remodeling jobs to support himself.
    From 1963 or 1964 until 1978 or 1979, Davis did one or two brake jobs a
    day, on average. For each brake job, he replaced old brake linings with new
    Bendix linings. Each brake job required the replacement of four linings; there
    were two linings per tire, two tires per axle. Before installing the new brake
    linings, Davis would sand each lining for one to two minutes. The sanding
    produced dust, which Davis would inhale. At the time Davis was performing
    brake jobs, Bendix linings were made up of resin material into which chrysotile
    asbestos fibers were mixed; the linings were 50 percent chrysotile asbestos by
    weight.3
    In addition to doing one or two brake jobs a day, Davis also did two or three
    home remodeling projects per month during that same period. The home
    remodeling work he did consisted of installing sheetrock and ceramic tile flooring.
    When installing sheetrock, Davis would apply a joint compound (also called
    3
    “Asbestos” is used to describe a number of different minerals that occur naturally
    in the environment; what they have in common is a fibrous structure. There are two main
    types of asbestos: serpentine (or chrysotile), and amphiboles, which include amosite and
    crocidolite. Amphibole fibers, which are straight fibers that can stay in the lungs for
    decades, are considered to be more potent or toxic than chrysotile fibers, which are wavy
    and generally stay in the lungs for months rather than years.
    4
    “mud”) that contained asbestos. To make the mud, Davis would open bags of dry
    powdered joint compound (which created inhalable dust) and mix the powder with
    water. After applying the mud and letting it dry, Davis would sand it, either by
    hand or a machine, to make it smooth. Using a sanding machine created a lot of
    dust, which would get all over his face and hair.
    In August 2011, Davis was diagnosed with malignant epithelial
    mesothelioma. In September 2011, he filed the instant lawsuit against Honeywell
    and other defendants.4 After Davis died in May 2012, plaintiff, as Davis’ personal
    representative, was substituted in place of Davis and filed a first amended
    complaint for wrongful death alleging causes of action for negligence, strict
    liability, false representation, and intentional failure to warn.
    A.    Motion in Limine
    A month and a half before trial (before any depositions of plaintiff’s experts
    had been taken), Honeywell filed a motion in limine to preclude plaintiff from
    presenting expert opinion testimony that every exposure to asbestos above
    background levels contributed to Davis’s mesothelioma, or that Davis’s exposure
    to “encapsulated, short fiber chrysotile asbestos from automotive brake products”
    contributed to his disease. Honeywell supported its motion with plaintiff’s
    supplemental responses to interrogatories, orders or transcripts in other cases (a
    federal district court case and two Los Angeles Superior Court cases) in which the
    court granted motions to preclude “every exposure” testimony, and copies of cases
    from a Pennsylvania Superior Court and the Supreme Court of Pennsylvania,
    Eastern District in which “every exposure” testimony was excluded. Plaintiff
    opposed the motion on the ground it was premature, and the matter was continued.
    4
    It appears that the only defendant remaining at the time of trial was Honeywell.
    5
    Honeywell renewed its motion in limine after taking the depositions of
    plaintiff’s medical experts, James A. Strauchen, M.D., a pathologist, and William
    Rom, M.D., a pulmonologist. It filed a supplement brief, along with excerpts from
    the depositions of both physicians. Both physicians testified at their depositions
    that they had reviewed Davis’ medical records and deposition transcript, and both
    opined that Davis’ exposure to asbestos from sanding the Bendix brake linings was
    a substantial contributing factor in the development of his mesothelioma. Dr.
    Strauchen was asked whether it would make any difference to his opinion if Davis
    had done only a single brake job (rather than one or two a day for many years, plus
    two or three home remodeling jobs per month); he responded that he would still
    consider that single exposure to be a contributing cause of his mesothelioma, but
    the fact that it was a single exposure might affect the way he would weigh
    contributing factors. Dr. Rom testified that, in his opinion, if a person did only one
    or two brake jobs in his life, the exposure he would have gotten from those jobs
    would not be a substantial factor in the development of mesothelioma, but if a
    person did a brake job five days a week for several months, the cumulative
    exposure could be a substantial factor. Both physicians discussed several studies
    and scientific articles that they asserted supported their opinions.
    After considering Honeywell’s supplemental brief, and hearing argument,
    the trial court denied Honeywell’s motion and allowed Dr. Strauchen to testify.
    B.    Trial
    At trial, plaintiff presented excerpts from Davis’ videotaped deposition in
    which Davis described, among other things, his work doing brake jobs and home
    remodeling projects from 1963 or 1964 through the late 1970s. In addition to her
    own testimony, plaintiff also presented the testimony of Dr. Strauchen and a public
    health expert, Dr. Barry Castleman.
    6
    In his direct examination, Dr. Strauchen testified about his training and
    experience as a pathologist. He described how the respiratory system functions,
    and what happens when a person develops mesothelioma. He explained the
    different types of asbestos and what happens when asbestos fibers are inhaled. He
    testified that the principal cause, and only proven cause, of mesothelioma is
    asbestos, and that Davis died from that disease. He also testified that both forms of
    asbestos (serpentine, or chrysotile, and amphibole) cause mesothelioma, and that
    mesothelioma can occur with very low doses of asbestos exposure. He explained
    that asbestos exposure is cumulative because the fibers stay in the lungs for a long
    time, so each exposure adds to the previous exposures. He also explained that
    asbestos-related diseases, particularly mesothelioma, exhibit extensive latent
    intervals, and that mesothelioma typically occurs 20 to 50 years after the exposure
    to asbestos.
    At the end of Dr. Strauchen’s direct examination, plaintiff’s counsel
    presented him with a hypothetical. Dr. Strauchen was asked to assume that a
    person did one to two brake jobs a day from 1962 to the late 1970s; for each job he
    sanded four brake liners for a minute or a minute and a half each, which created
    visible dust that he breathed in; and each brake liner contained 50 percent asbestos
    and 50 percent binder. Based on those assumed facts, he was asked whether that
    exposure was a substantial contributing factor in the causation of that person’s
    mesothelioma. Dr. Strauchen said that in his opinion, it was, and that he held that
    opinion within a reasonable degree of medical certainty.
    On cross-examination, Dr. Strauchen admitted that he did not perform any
    calculations or estimates of the dose of asbestos Davis may have received from any
    of the activities he engaged in. He testified, however, that he was familiar with an
    article that found that respirable asbestos fibers come off brake linings when they
    are washed with distilled water, and that it is generally accepted that if there is
    7
    visible dust from a product made from asbestos, it would include a substantial
    amount of asbestos.5 Dr. Strauchen also conceded that there are postulated causes
    of mesothelioma other than asbestos, but he said that asbestos was the only proven
    cause, and that up to 90 percent of men with mesothelioma have had asbestos
    exposure. He also admitted that everyone has some exposure to asbestos because
    small amounts of asbestos are present in the air we breathe, and that that exposure
    – referred to as background or ambient exposure – generally is not considered a
    substantial cause of mesothelioma, although he did not rule out that background
    exposure may be responsible for some cases of mesothelioma.
    Plaintiff’s other expert, Dr. Barry Castleman, testified regarding reports and
    articles that have been published, beginning in the 1890s, warning of the dangers
    of asbestos exposure. The trial court instructed the jury that the purpose of Dr.
    Castleman’s testimony was not to say whether the conclusions reached in those
    reports and articles were correct, but rather to show whether Bendix had notice of
    possible dangers. Some of the reports or articles Dr. Castleman discussed
    specifically addressed the hazards of asbestos exposure in mechanics working on
    automobile brakes.
    In its case-in-chief, Honeywell presented expert testimony from an
    epidemiologist, an industrial hygienist, a pathologist, and an expert in brakes and
    brake safety. The epidemiologist, Dr. David Garabrant, testified about
    epidemiological studies that examined whether people employed full time as
    vehicle mechanics were at an increased risk for mesothelioma. In 2004, Dr.
    Garabrant had published in a peer-reviewed journal a meta-analysis examining all
    such epidemiological studies up to that time, and concluded there was no
    5
    Dr. Strauchen referred to one article that estimated that visible dust would contain
    five to ten fibers per cc, which he testified is substantially more than the OSHA limit of
    0.1 fiber per cc.
    8
    association between employment as a mechanic and the risk of mesothelioma. He
    conducted a subsequent meta-analysis to include epidemiological studies done
    after 2004, and came to the same conclusion.
    Industrial hygienist Kenneth White testified about how asbestos exposure is
    measured, and the exposure limits issued by the Occupational Safety and Health
    Administration (OSHA). He estimated Davis’ probable exposure from his work
    with brakes, and concluded that his cumulative exposure was below the OSHA
    limits. He also testified that extremely high heat applied to the brake linings
    converts asbestos fibers into non-toxic substances.
    Pathologist Dr. Michael Graham opined that exposure to brake dust does not
    cause mesothelioma. He testified that he was not aware of any study that showed
    that low exposure to chrysotile causes mesothelioma.
    Brake expert Richard Radlinski testified about how brakes work, why
    chrysotile asbestos was used in brakes, and what goes into the development of
    brake linings.
    C.    Jury Instructions, Deliberations and Verdict
    Honeywell proposed a special jury instruction on causation that stated: “The
    parties dispute whether Sam Davis’s claimed exposure to asbestos-containing
    Bendix brakes was a substantial factor in causing his mesothelioma. [¶] Many
    factors are relevant in assessing the medical probability that any alleged asbestos
    exposure was a substantial factor in causing an injury. These factors include the
    type of asbestos, the nature of the exposure, the frequency of exposure, the
    regularity of exposure, the duration of exposure, the proximity of the asbestos-
    containing product, and the type of asbestos-containing product.” The trial court
    refused that instruction, and instead instructed the jury using CACI No. 435
    (Causation for Asbestos-Related Cancer Claims), as follows: “A substantial factor
    9
    in causing harm is a factor that a reasonable person would consider to have
    contributed to the harm. It does not have to be the only cause of the harm. [¶]
    Nickole Davis may prove that exposure to asbestos from Honeywell International
    Inc.’s product was a substantial factor causing Sam Davis’ illness by showing,
    through expert testimony, that there is a reasonable medical probability that the
    exposure was a substantial factor contributing to his risk of developing cancer.”
    In the afternoon of the jury’s first day of deliberations, the jury sent a note to
    the judge, asking for a definition of “substantial” in question 4 of the special
    verdict form.6 The judge referred the jury to the “Causation for Asbestos-Related
    Cancer Claims” instruction already given. The following morning, the jury sent
    another note to the judge, asking whether the jury could either strike the word
    “substantial” from the questions on the special verdict form or just say “factor” in
    those questions. The judge responded that the jury was required to follow the
    instruction previously identified.
    The jury reached its verdict the next day. The jury found against Honeywell
    on all but one of plaintiff’s claims (it found in favor of Honeywell on plaintiff’s
    strict liability claim for design defect under a risk-benefit theory) and found the
    total amount of damages suffered by plaintiff was $2 million. It allocated 85
    percent of the fault to Honeywell, and the remaining 15 percent in equal shares to
    each of the eight companies responsible for Davis’ asbestos exposure from his
    home remodeling jobs. Judgment was entered on the verdict, and Honeywell
    timely filed a notice of appeal from the judgment.
    6
    Question 4 asked: “Was the failure of Bendix brakes to perform as safely as an
    ordinary consumer would have expected them to perform a substantial factor in causing
    Sam Davis’ mesothelioma?”
    10
    DISCUSSION
    Honeywell contends the judgment must be reversed because (1) the trial
    court failed to properly exercise its gatekeeper role and exclude Dr. Strauchen’s
    expert opinion testimony that was based upon an “every exposure” theory, and
    (2) the trial court erroneously refused to instruct the jury with Honeywell’s
    proposed special instruction on causation, which prejudiced Honeywell.
    A.     Admissibility of Dr. Strauchen’s Testimony
    In 
    Sargon, supra
    , 
    55 Cal. 4th 747
    , the California Supreme Court examined
    the trial court’s duty to act as a “gatekeeper” with regard to expert testimony. The
    Court observed that, under Evidence Code sections 801 and 802, the trial court
    must “act[] as a gatekeeper to exclude expert opinion testimony that is (1) based on
    matter of a type on which an expert may not reasonably rely, (2) based on reasons
    unsupported by the material on which the expert relies, or (3) speculative.” (Id. at
    pp. 771-772.) The Court cautioned, however, that “[t]he trial court’s gatekeeping
    role does not involve choosing between competing expert opinions.” (Id. at p.
    772.) Importantly, “[t]he court does not resolve scientific controversies. Rather, it
    conducts a ‘circumscribed inquiry’ to ‘determine whether, as a matter of logic, the
    studies and other information cited by experts adequately support the conclusion
    that the expert’s general theory or technique is valid.’ [Citation.] The goal of trial
    court gatekeeping is simply to exclude ‘clearly invalid and unreliable’ expert
    opinion. [Citation.] In short, the gatekeeper’s role ‘is to make certain that an
    expert, whether basing testimony upon professional studies or personal experience,
    employs in the courtroom the same level of intellectual rigor that characterizes the
    practice of an expert in the relevant field.’ [Citation.]” (Ibid.) A trial court’s
    ruling excluding or admitting expert testimony is reviewed for abuse of discretion.
    (Id. at p. 773.)
    11
    In this case, Honeywell contends the trial court erred by admitting Dr.
    Strauchen’s testimony because (1) his opinion was speculative and illogical; (2) the
    regulatory standards he relied upon cannot establish causation; (3) no appropriate
    scientific literature supports his theory, and epidemiology studies contradict it; and
    (4) the “every exposure” theory is contrary to California causation law as set forth
    in 
    Rutherford, supra
    , 
    16 Cal. 4th 953
    . We conclude the trial court did not abuse its
    discretion in admitting the testimony.
    1.     Speculative/Illogical
    Honeywell argues that Dr. Strauchen’s opinion that every one of Davis’
    exposures to asbestos contributed to Davis’ mesothelioma, except for his exposure
    to background or ambient levels, is speculative and illogical. It asserts that Dr.
    Strauchen gave contradictory testimony by conceding that there is no scientific
    support for the proposition that background levels of asbestos exposure can be a
    substantial factor contributing to the disease, while also testifying that any
    exposure to asbestos from working on brake linings is a substantial factor.
    Similarly, it asserts that Dr. Strauchen’s testimony that mesothelioma is dose
    dependent (i.e., the greater the exposure, the greater the risk of developing the
    disease) cannot be reconciled with his opinion that every exposure, even very low
    exposures, can be a substantial factor in causing the disease. Neither of these
    examples demonstrates that Dr. Strauchen’s testimony was speculative or illogical.
    First, Dr. Strauchen did not concede that exposure to background levels of
    asbestos cannot be a substantial factor in causing mesothelioma. Instead, he
    testified that “[v]ery little is actually known about the health effects of the ambient
    exposure. Since everybody has it, it’s exceedingly difficult to study because there
    is no control group. You can’t find anybody who does not have that exposure; and
    although it’s not considered a substantial cause of mesothelioma, it’s possible that
    12
    some of those cases . . . where there is absolutely no other exposure are actually
    due to the ambient asbestos we are all exposed to.” In other words, Dr. Strauchen
    posited that because it is difficult to create a valid study, background exposure has
    not been scientifically deemed a substantial factor in causing mesothelioma.
    Nonetheless, there may be cases in which, where no other exposure has occurred,
    background exposure is a substantial factor in causing mesothelioma. That opinion
    is consistent with his opinion that other low levels of exposure can be a substantial
    factor.
    Second, the fact that mesothelioma is dose dependent does not render Dr.
    Strauchen’s opinion that every exposure can be a substantial factor in causing the
    disease illogical. Nor does it, as Honeywell asserts, necessarily treat the
    correlation between exposure and risk of disease as purely linear. Dr. Strauchen
    explained that asbestos exposure is cumulative, because asbestos fibers stay in the
    lung for long periods of time. Therefore, even if there is a threshold level of
    exposure below which there is no likelihood of developing mesothelioma, it is not
    illogical to conclude that each exposure – even a low exposure – when added to
    other exposures (including other low exposures) could result in a cumulative
    exposure that is above the threshold level, giving rise to the risk of developing
    mesothelioma.
    We emphasize that in acknowledging this conclusion, we do not mean to
    imply it is the only conclusion that can be reached regarding low exposures to
    asbestos. We simply recognize that, in light of Dr. Strauchen’s testimony
    regarding the properties of asbestos and how it affects a person’s lungs, his
    reasoning is neither speculative nor illogical.
    13
    2.     Regulatory Standards
    Honeywell asserts that Dr. Strauchen’s testimony should have been excluded
    because he improperly relied upon regulatory standards promulgated by regulatory
    agencies such as OSHA to support his theory that every exposure to chrysotile
    asbestos raises the risk of developing mesothelioma. It argues that regulatory
    standards cannot be used to establish causation because those standards are
    prophylactic in nature, and may be based upon evidence that gives rise only to a
    suspicion of causation. (See Matrixx Initiatives, Inc. v. Siracusano (2011) 
    563 U.S. 27
    [
    131 S. Ct. 1309
    , 1320] [regulatory agency often makes regulatory
    decisions based upon evidence that gives rise only to a suspicion of causation];
    McClain v. Metabolife Intern., Inc. (11th Cir. 2005) 
    401 F.3d 1233
    , 1250 [public
    health guidelines cannot be used to establish causation because they are based
    upon evidence that points to a need for caution rather than proof of a causal
    relationship]; Rider v. Sandoz Pharmaceuticals Corp. (11th Cir. 2002) 
    295 F.3d 1194
    , 1201 [improper for medical causation expert to rely upon FDA statement
    withdrawing approval of drug for some purposes because FDA used a risk-utility
    analysis, which involves a much lower standard than required to show legal
    causation].) Honeywell also observes that even if regulatory standards could be
    used to support an expert’s opinion, the OSHA standards for exposure to asbestos
    do not distinguish between different types of asbestos (or the toxicity of those
    different types), and in any event, Dr. Strauchen did not determine whether Davis’
    exposure from the Bendix brake linings exceeded the OSHA exposure limit.
    Honeywell misconstrues Dr. Strauchen’s references to the regulatory
    agencies and their standards. Dr. Strauchen did not rely upon the regulatory
    standards to develop his opinion; he testified that he relied upon his own research
    and the scientific literature regarding the relationship between asbestos exposure
    and mesothelioma and other lung diseases. He merely referred to OSHA and other
    14
    regulatory bodies to show that there is a consensus that all forms of asbestos are
    carcinogenic, and noted that OSHA, by indicating that there is no guarantee that
    disease does not occur below its prescribed exposure limit, acknowledges that
    there is no identified level of exposure below which disease does not occur. Those
    references do not render Dr. Strauchen’s testimony inadmissible under Sargon.
    Moreover, to the extent Dr. Strauchen relied upon studies conducted or
    relied upon by OSHA or any other regulatory agencies, his reliance was not
    improper. As the Eleventh Circuit noted in one of the cases Honeywell cites, the
    data regulatory agencies use to establish their standards “‘are useful for both . . .
    establishing guidelines for protection of public health and establishing
    “causation.”’” (McClain v. Metabolife Intern., 
    Inc., supra
    , 401 F.3d at p. 1249.)
    3.     Scientific Literature/Epidemiological Studies
    Honeywell argues that Dr. Strauchen’s testimony was not supported by the
    materials he relied upon because he admitted there have been no studies at the low
    exposure level that Davis experienced from working with Bendix brake liners, and
    there are several epidemiological studies that have shown no association between
    employment as a motor vehicle mechanic and the risk of mesothelioma. It asserts
    that Dr. Strauchen improperly extrapolated down from studies involving high-dose
    exposures to amphibole asbestos to draw conclusions regarding low-dose
    exposures to chrysotile asbestos, and ignored the epidemiological studies, which it
    contends are the best evidence of causation in toxic tort cases.
    However, Honeywell’s arguments rest upon premises that are not correct.
    First, Dr. Strauchen’s “admission” at trial was not exactly what Honeywell asserts.
    He was asked, “But there have been no studies at that low exposure level [meaning
    OSHA’s exposure limit] that specifically have identified a minimum level of
    increased risk; isn’t that true?” Dr. Strauchen responded that that was correct. But
    15
    this “admission” is not, as Honeywell implies, an admission that there have been
    no studies of the association between mesothelioma and the kind of low dose
    exposure Davis experienced. In fact, when asked at his deposition what scientific
    articles he relied upon in reaching his opinion that Davis’ work with brake dust
    caused his mesothelioma, Dr. Strauchen (who noted that he could not name off the
    top of his head all of the studies he reviewed) named three studies.7 8
    One of the named studies, by Jacques Ameille and other French scientists,
    was published in The Annals of Occupational Hygiene in 2012. The scientists
    studied 103 French automobile mechanics with no other known occupational
    exposure to asbestos and found a five percent incidence of pleural plaques.
    (Ameille, et al., Asbestos-Related Diseases in Automobile Mechanics (2011) 56
    Ann.Occup.Hyg. 55-60.) Dr. Strauchen testified that if the levels of exposure are
    enough to cause pleural plaques, they would be high enough to cause
    mesothelioma.
    The second study that Dr. Strauchen identified was a cancer registry study in
    Massachusetts. That study, by Cora R. Roelofs and other scientists, was published
    in the American Journal of Industrial Medicine in 2013, and was based upon an
    examination of mesothelioma and other cancer cases recorded in the Massachusetts
    Cancer Registry (the MCR) from 1988 to 2003. (Roelofs, et al., Mesothelioma and
    7
    At oral argument, counsel for Honeywell argued that we should consider only the
    testimony at trial, and noted that Dr. Strauchen did not cite these studies in his trial
    testimony. But Honeywell moved to exclude Dr. Strauchen’s testimony based upon his
    (and Dr. Rom’s) deposition testimony, and we are reviewing the trial court’s denial of
    that motion. Thus, we must look to the deposition testimony “to ‘determine whether, as a
    matter of logic, the studies and other information cited by experts adequately support the
    conclusion that the expert’s general theory or technique is valid.’” 
    (Sargon, supra
    , 55
    Cal.4th at p. 772.)
    8
    Dr. Rom also testified at his deposition that there have been studies that describe
    the risk of mesothelioma at low-dose exposures.
    16
    Employment in Massachusetts: Analysis of Cancer Registry Data 1988-2003
    (2013) 56 Am.J.Ind.Med. 985-992.) Since 1982, all hospitals or organizations
    holding a clinical license in Massachusetts have been required to report newly
    diagnosed cancer cases to the MCR, with diagnostic and demographic information,
    including descriptions of the patient’s usual occupation and industry. Using this
    data, the authors of the study examined the association between mesothelioma
    incidence and usual occupation and industry, and found that 17 occupations –
    including automobile mechanics – had statistically significant elevated
    “Standardized Morbidity Odds Ratios” for mesothelioma. Although the authors
    noted that a major limitation of a cancer registry-based surveillance study is that
    the reported usual occupation and industry may not include all possible sources of
    asbestos exposures, they nevertheless concluded that their findings support the
    continued monitoring of automobile mechanics and efforts to prevent their
    exposure to asbestos.
    The third study Dr. Strauchen identified, by James Leigh and other
    scientists, analyzed data from the Australian Mesothelioma Surveillance Program
    and the Australian Mesothelioma Register. (Leigh, et al., Malignant Mesothelioma
    in Australia, 1945-2000 (2002) 46 Ann.Occup.Hyg. 160-165.) According to the
    authors, Australia has one of the world’s most complete national surveillance
    systems for mesothelioma, which has been in operation since January 1980. (Id. at
    p. 160.) Cases of mesothelioma are reported to the Australian Mesothelioma
    Register (from 1980 to 1986, the cases were reported to the Australian
    Mesothelioma Surveillance Program), and a full occupational and environmental
    history is obtained for each case from the patient or next of kin. (Id. at pp. 160-
    161.) The authors investigated, among other things, associations between
    mesothelioma and occupational and environmental asbestos exposure histories, and
    lifetime risks for mesothelioma in different exposure categories. They found that
    17
    four percent of the cases reported had exposure only to chrysotile. (Id. at p. 164.)
    They also found that two percent of the cases had exposure to brake linings. (Ibid.)
    Finally, they found that the lifetime risk of mesothelioma for vehicle mechanics
    was nearly double that of all Australian men. (Ibid.)
    In addition to those three studies, Dr. Strauchen also pointed to an article by
    Dr. Richard Lemen, the former Assistant Surgeon General with the United States
    Public Health Service and retired Deputy Director and Acting Director of the
    National Institute for Occupational Safety and Health. Dr. Lemen’s article, which
    was published in the American Journal of Industrial Medicine in 2004, discussed
    studies that looked at the decomposition of asbestos fibers in brake linings, the
    toxicity of short chrysotile asbestos fibers (Dr. Lemen noted that some studies have
    reported that the majority of chrysotile fibers from brakes that remain during
    decomposition are short fibers), and exposure levels of asbestos released from
    brakes. Dr. Lemen also discussed the evidence of disease in persons exposed to
    asbestos from brakes, including evidence from epidemiological studies and
    numerous case reports of people with mesothelioma or other asbestos-related
    diseases who were exposed to chrysotile asbestos through brake work. (Lemen,
    Asbestos in Brakes: Exposure and Risk of Disease (2004) 45 Am.J.Ind.Med. 229.)
    These studies and article belie Honeywell’s assertion that Dr. Strauchen
    admitted there are no studies of the association between mesothelioma and the kind
    of low dose exposure Davis experienced from Bendix brake linings.
    The second faulty premise for Honeywell’s argument that there is no
    scientific support for Dr. Strauchen’s opinion testimony is its assertion regarding
    epidemiological studies. While Honeywell is generally correct that in many (or
    even most) instances epidemiological studies provide the best evidence of
    causation, its implied argument that it is improper for an expert to rely upon any
    18
    other tools to determine causation, such as case reports,9 is not universally
    accepted. Indeed, a well-regarded textbook on occupational epidemiology
    observes that “[c]ase series reports are particularly informative in situations where
    there are identified occurrences of very rare conditions for which there are few, if
    any, established causal factors. . . . In fact, recognition of even a small number of
    cases of the ‘sentinel’ diseases – such as liver angiosarcoma and malignant
    mesothelioma, which is strongly related to asbestos exposure [citation] – can
    sometimes be invoked as prima facie evidence of exposure to the putative causal
    agent.” (Occupational 
    Epidemiology, supra
    , at p. 60.) The textbook goes on to
    discuss other kinds of epidemiological studies, such as cohort studies and case-
    control studies (i.e., the kinds of studies that Honeywell asserts are the best
    evidence of causation) and concludes that case series reports can be sufficient by
    themselves for drawing conclusions regarding causation for diseases, like
    mesothelioma, that are very rare with one major causal factor: “Case series reports
    can be virtually conclusive in their own right when the health outcome identified is
    a very rare disease or an uncommon manifestation of a relatively common
    condition.” (Id. at p. 78.)
    In short, Honeywell’s assertion that Dr. Strauchen’s testimony was not
    supported by the materials he relied upon is not correct. Although Honeywell –
    and others – may disagree about the methods used in those materials or the
    conclusions Dr. Strauchen drew from them (see, e.g., Anderson, et al., The “Any
    Exposure” Theory Round II – Court Review of Minimal Exposure Expert
    9
    Case reports are reports by a clinician of the occurrence of a disease in a particular
    individual. When there are multiple case reports regarding an unusual occurrence of a
    certain disease among a group, the study is referred to as a case series report. (H.
    Checkoway, et al., Research Methods in Occupational Epidemiology (2d ed. 2004) p. 59
    (Occupational Epidemiology).)
    19
    Testimony in Asbestos and Toxic Tort Litigation Since 2008 (2012) 22
    Kan.J.L.&Pub.Pol’y 1), many members of the scientific community do not (see,
    e.g., Welch, et al., Asbestos Exposure Causes Mesothelioma, But Not This
    Asbestos Exposure: An Amicus Brief to the Michigan Supreme Court (2007) 13
    Int.J.Occup.Environ.Health 318).
    We caution that our discussion of the materials Dr. Strauchen relied upon
    should not be seen as approval of either side in that scientific dispute. Rather, we
    rely upon the rule of Sargon that although trial courts “have a substantial
    ‘gatekeeping’ responsibility” in evaluating proposed expert opinion 
    (Sargon, supra
    , 55 Cal.4th at p. 769), the gate tended is not a partisan checkpoint. It bars
    expert opinion only if it fails to meets the minimum qualifications for admission.
    If the opinion is based on materials on which the expert may reasonably rely in
    forming the opinion, and flows in a reasoned chain of logic from those materials
    rather than from speculation or conjecture, the opinion may pass, even though the
    trial court or other experts disagree with its conclusion or the methods and
    materials used to reach it. (Id. at pp. 771-772.) The aim, as we have stated, is not
    to admit only persuasive expert opinion; it is to exclude only “‘clearly invalid and
    unreliable’ expert opinion,” that is, opinion that does not employ the “‘same level
    of intellectual rigor that characterizes the practice of an expert in the relevant
    field.’ [Citation.]” (Id. at p. 772.) Here, it is clear that there is support in the
    scientific literature for Dr. Strauchen’s expert opinion, and it cannot be said that his
    opinion fails to adhere to standards applicable to his field of expertise.
    4.     California Causation Law
    In Honeywell’s final challenge to Dr. Strauchen’s testimony, it argues that
    the “every exposure” theory does not satisfy the Supreme Court’s direction in
    Rutherford that a causation analysis must proceed from an estimate concerning
    20
    how great a dose was received. (Citing 
    Rutherford, supra
    , 16 Cal.4th at pp. 969,
    975, 982.) Because Dr. Strauchen did not attempt to undertake any “dose level
    estimations” and was not provided with a “dose level estimation,” Honeywell
    argues that Dr. Strauchen did not comply with Rutherford.
    However, contrary to Honeywell’s assertion, Rutherford does not require a
    “dose level estimation.” Instead, it requires a determination, to a reasonable
    medical probability, that the plaintiff’s (or decedent’s) exposure to the defendant’s
    asbestos-containing product was a substantial factor in contributing to the risk of
    developing mesothelioma. 
    (Rutherford, supra
    , 16 Cal.4th at pp. 976-977.) The
    Rutherford court itself acknowledged that a plaintiff may satisfy this requirement
    through the presentation of expert witness testimony that “each exposure, even a
    relatively small one, contributed to the occupational ‘dose’ and hence to the risk of
    cancer.” (Id. at p. 984.)
    In any event, in this case, Dr. Strauchen was presented with a hypothetical
    based on the facts surrounding Davis’ exposure to dust from his work on Bendix
    brake linings, and testified as to estimates of the amount of asbestos fibers
    contained in visible dust. Therefore, his conclusion that Davis’ exposure to Bendix
    brake linings was a substantial factor in contributing to the risk of mesothelioma
    was not based simply on “any exposure” to asbestos, but instead related to an
    estimate of actual exposure.
    5.     Cases From Other Jurisdictions
    As additional support for its argument that the “every exposure” theory
    should be rejected by this court, Honeywell points to cases from other jurisdictions
    in which courts have rejected that theory. (Citing, among other cases, Betz v.
    Pneumo Abex, LLC (2012) 
    615 Pa. 504
    [
    44 A.3d 27
    ] (Betz); Bostic v. Georgia-
    Pacific Corp. (Tex. 2014) 
    439 S.W.3d 332
    (Bostic); Moeller v. Garlock Sealing
    21
    Technologies, LLC (6th Cir. 2011) 
    660 F.3d 950
    (Moeller).) We are not
    convinced.
    First, and foremost, we are bound by our Supreme Court, which issued a
    clear statement of a plaintiff’s burden in an asbestos-related cancer case – to
    demonstrate that the defendant’s product was a substantial factor in contributing to
    the plaintiff’s aggregate dose of asbestos and hence to the risk of developing
    mesothelioma – and affirmed the judgment in favor of the plaintiff where the
    plaintiff met her burden through an expert witness who testified that each exposure
    to asbestos contributed to the aggregate dose and hence to the risk of cancer.
    
    (Rutherford, supra
    , 16 Cal.4th at pp. 976-977, 984.)
    Second, the standards required by other jurisdictions for establishing
    causation differ from those in California. For example, in Texas, “in the absence
    of direct proof of causation, establishing causation in fact against a defendant in an
    asbestos-related disease case requires scientifically reliable proof that the
    plaintiff’s exposure to the defendant’s product more than doubled his risk of
    contracting the disease.” 
    (Bostic, supra
    , 439 S.W.3d at p. 350.) There is no such
    requirement in California. Similarly, under Kentucky law (which governed
    Moeller), a plaintiff in an asbestos-related disease case must show that exposure to
    the defendant’s asbestos-containing product was a substantial cause of the disease
    – i.e., that it was “the probable cause, as opposed to a possible cause” 
    (Moeller, supra
    , 660 F.3d at p. 954) – and therefore a plaintiff cannot prevail by showing
    only that his exposure may have contributed to his disease. (Id. at p. 955.) In
    contrast, our Supreme Court has held that the plaintiff need not “demonstrate that
    fibers from the defendant’s particular product were the ones, or among the ones,
    that actually produced the malignant growth,” 
    (Rutherford, supra
    , 16 Cal.4th at p.
    977), and may prevail by demonstrating that the defendant’s product was a
    22
    substantial factor in contributing to the risk of developing asbestos-related cancer.
    (Id. at pp. 976-977.)
    Finally, we simply disagree with courts in other jurisdictions that conclude
    the “every exposure” theory cannot be reconciled with the fact that mesothelioma
    and other asbestos-related diseases are dose dependent. (See, e.g., 
    Betz, supra
    , 615
    Pa. at pp. 546, 550 [44 A.3d at pp. 53, 56]; 
    Bostic, supra
    , 439 S.W.3d at pp. 338-
    339.) As we discussed in section A.1., ante, if (as in this case) the expert testifies
    that asbestos exposure is cumulative because the fibers remain in the lungs for a
    long period of time, it is not illogical to conclude that each exposure, when added
    to other exposures, can result in a cumulative exposure sufficient to cause
    mesothelioma or other asbestos-related diseases, and therefore each exposure is a
    substantial factor in contributing to the disease. Indeed, our Supreme Court has
    expressly stated that “[a]lthough the plaintiff must, in accordance with traditional
    tort principles, demonstrate to a reasonable medical probability that a product or
    products supplied by the defendant, to which he became exposed, were a
    substantial factor in causing his disease or risk of injuries, he is free to further
    establish that his particular asbestos disease is cumulative in nature, with many
    separate exposures each having constituted a ‘substantial factor’ [citation] that
    contributed to his risk of injury.” 
    (Rutherford, supra
    , 16 Cal.4th at p. 958.)
    B.     Denial of Honeywell’s Proposed Jury Instruction
    As noted, Honeywell proposed a special jury instruction on causation, which
    the trial court refused to give.10 Honeywell contends the trial court’s refusal to
    10
    The proposed instruction stated: “The parties dispute whether Sam Davis’s
    claimed exposure to asbestos-containing Bendix brakes was a substantial factor in
    causing his mesothelioma. [¶] Many factors are relevant in assessing the medical
    probability that any alleged asbestos exposure was a substantial factor in causing an
    injury. These factors include the type of asbestos, the nature of the exposure, the
    23
    give the proposed instruction was error, and that Honeywell was prejudiced by that
    error. We find there was no error.
    “‘A party is entitled upon request to correct, nonargumentative instructions
    on every theory of the case advanced by him which is supported by substantial
    evidence.’ [Citation.]” (Major v. Western Home Ins. Co. (2009) 
    169 Cal. App. 4th 1197
    , 1217.) “[T]he duty of the court is fully discharged if the instructions given
    by the court embrace all the points of the law arising in the case. [Citations.] [¶]
    A party is not entitled to have the jury instructed in any particular phraseology and
    may not complain on the ground that his requested instructions are refused if the
    court correctly gives the substance of the law applicable to the case. [Citation.]”
    (Hyatt v. Sierra Boat Co. (1978) 
    79 Cal. App. 3d 325
    , 335; see also Fibreboard
    Paper Products Corp. v. East Bay Union of Machinists (1964) 
    227 Cal. App. 2d 675
    , 719 [“Error cannot be predicated on the trial court’s refusal to give a
    requested instruction if the subject matter is substantially covered by the
    instructions given”].) We review the legal adequacy of jury instructions under the
    de novo standard of review. (Isip v. Mercedes-Benz USA, LLC (2007) 
    155 Cal. App. 4th 19
    , 24.)
    In this case, Honeywell argues the trial court’s refusal to give its proposed
    instruction was error because the instruction set forth “the requirement in
    Rutherford that causation be decided by taking into account ‘the length, frequency,
    proximity and intensity of exposure, the peculiar properties of the individual
    product, [and] any other potential causes to which the disease could be attributed.’”
    (Quoting 
    Rutherford, supra
    , 16 Cal.4th at p. 975.) But Rutherford does not require
    the jury to take these factors into account when deciding whether a plaintiff’s
    exposure to an asbestos-containing product was a substantial factor in causing
    frequency of exposure, the regularity of exposure, the duration of exposure, the proximity
    of the asbestos-containing product, and the type of asbestos-containing product.”
    24
    mesothelioma. Instead, those factors are ones that a medical expert may rely upon
    in forming his or her expert medical opinion.
    The language Honeywell quotes appears in the Supreme Court’s discussion
    of “the medical problems and uncertainties accompanying factual proof of
    causation in an asbestos cancer case” 
    (Rutherford, supra
    , 16 Cal.4th at p. 974), in
    the context of determining whether it is appropriate to shift the burden of proof
    from the plaintiff to the defendant, and require the defendant to prove that its
    product was not a cause of the plaintiff’s mesothelioma. The Court noted that “[a]t
    the most fundamental level, there is scientific uncertainty regarding the biological
    mechanisms by which inhalation of certain microscopic fibers of asbestos leads to
    lung cancer and mesothelioma.” (Ibid.) The Court observed there is a question
    whether lung cancer and mesothelioma are caused by a single fiber or group of
    fibers that causes the formation of a tumor, or whether each episode of scarring by
    fibers contributes cumulatively to the formation of a tumor or the conditions
    allowing such a formation. (Id. at pp. 974-975.) Next, the Court noted, “[a]part
    from the uncertainty of the causation, at a much more concrete level uncertainty
    frequently exists whether the plaintiff was even exposed to dangerous fibers from a
    product produced, distributed or installed by a particular defendant. . . . [¶]
    Finally, at a level of abstraction somewhere between the historical question of
    exposure and the unknown biology of carcinogenesis, the question arises whether
    the risk of cancer created by a plaintiff’s exposure to a particular asbestos-
    containing product was significant enough to be considered a legal cause of the
    disease. Taking into account the length, frequency, proximity and intensity of
    exposure, the peculiar properties of the individual product, any other potential
    causes to which the disease could be attributed (e.g., other asbestos products,
    cigarette smoking), and perhaps other factors affecting the assessment of
    comparative risk, should inhalation of fibers from the particular product be deemed
    25
    a ‘substantial factor’ in causing the cancer?” (Id. at p. 975.) The Court concluded
    that “[p]laintiffs cannot be expected to prove the scientifically unknown details of
    carcinogenesis, or trace the unknowable path of a given asbestos fiber. But the
    impossibility of such proof does not dictate use of a burden shift. Instead, we can
    bridge this gap in the humanly knowable by holding that plaintiffs may prove
    causation in asbestos-related cancer cases by demonstrating that the plaintiff’s
    exposure to defendant’s asbestos-containing product in reasonable medical
    probability was a substantial factor in contributing to the aggregate dose of
    asbestos the plaintiff or decedent inhaled or ingested, and hence to the risk of
    developing asbestos-related cancer, without the need to demonstrate that fibers
    from the defendant’s particular product were the ones, or among the ones, that
    actually produced the malignant growth.” (Id. at pp. 976-977, fn. omitted.)
    Following this discussion, the Supreme Court discussed how the jury should
    be instructed. It noted that “[t]he generally applicable standard instructions on
    causation [i.e., BAJI Nos. 3.76 and 3.77] are insufficient” because they do not
    “inform the jury that, in asbestos-related cancer cases, a particular asbestos-
    containing product is deemed to be a substantial factor in bringing about the injury
    if its contribution to the plaintiff or decedent’s risk or probability of developing
    cancer was substantial.” 
    (Rutherford, supra
    , 16 Cal.4th at p. 977.) Therefore, the
    Court instructed that “the jury should be told that the plaintiff’s or decedent’s
    exposure to a particular product was a substantial factor in causing or bringing
    about the disease if in reasonable medical probability it was a substantial factor
    contributing to plaintiff’s or decedent’s risk of developing cancer.” (Ibid.)
    The instructions given to the jury in this case included such an instruction.
    The jury was instructed that “[a] substantial factor in causing harm is a factor that a
    reasonable person would consider to have contributed to the harm. It does not
    have to be the only cause of the harm. [¶] Nickole Davis may prove that exposure
    26
    to asbestos from Honeywell International Inc.’s product was a substantial factor
    causing Sam Davis’ illness by showing, through expert testimony, that there is a
    reasonable medical probability that the exposure was a substantial factor
    contributing to his risk of developing cancer.”
    Honeywell’s proposed instruction was unnecessary because it was not
    directed to facts that the jury was required to decide. While Honeywell was free to
    discuss during its closing argument the factors set forth in its proposed instruction
    as factors the jury might consider in assessing the credibility of Dr. Strauchen’s
    opinion testimony, instructing the jury on those factors was not required. The fact
    that the jury asked for further instruction on the meaning of “substantial” as it
    related to “a substantial factor in causing Sam Davis’ mesothelioma” and asked
    whether it could strike the word “substantial” from the special verdict form does
    not demonstrate, as Honeywell suggests, that the proposed instruction would have
    helped to avoid the jury’s confusion. Rather, the jury’s questions simply suggest
    that at least some of the jurors initially were uncertain about how important a
    factor Davis’ exposure from Bendix’s brake linings needed to be in order to be
    deemed a “substantial” factor in causing his mesothelioma. Honeywell’s proposed
    instruction did not address this uncertainty.
    In short, because we find the jury was properly instructed on causation, the
    trial court’s refusal to give Honeywell’s proposed instruction was not error.
    //
    //
    //
    //
    //
    //
    27
    DISPOSITION
    The judgment is affirmed. Plaintiff shall recover her costs on appeal.
    CERTIFIED FOR PUBLICATION
    WILLHITE, Acting P. J.
    We concur:
    MANELLA, J.
    COLLINS, J.
    28
    

Document Info

Docket Number: B256793

Citation Numbers: 245 Cal. App. 4th 477, 199 Cal. Rptr. 3d 583, 2016 Cal. App. LEXIS 169

Judges: Willhite, Manella, Collins

Filed Date: 3/3/2016

Precedential Status: Precedential

Modified Date: 11/3/2024